TORONTO--(Marketwire - May 18, 2011) - Therma-Med, Inc. (PINKSHEETS: THRA) ("the Company") would like to announce it has signed an LOI to purchase Interest in Silver property in British Columbia, Canada.
The Property of interest is located within the Mining Division of Slocan, B.C., Canada. The property's geology is part of a Northwest-trending belt of sedimentary rocks called the Slocan Group. Further information regarding the LOI and the property details remain confidential and will be released immediately when the deal has been finalized.
The letter on Intent is subject to an "Exclusivity Period" until June 01, 2011, during which both parties agree to negotiate the final terms and conditions for the Definitive Agreement. The LOI will be superseded by a definite agreement and closing will be subject to several conditions including and limited to, completion of satisfactory due diligence and the receipt of required third party consents. During the Exclusivity period and until the closing date, THRA shall continue to operate its business in the ordinary course.
"I believe that this business decision can bring the company to new and higher levels much faster than if Therma remained at the stage where it was before this turnover. With the guidance and participation on this project of Zajay Trujillo, I see this as a win-win situation for all of our shareholders as this step has a strong potential to increase their value and secure significant future growth for the company," said Joshua Suarez, President of Therma-Med, Inc.
About Therma-Med, Inc.:
Therma-Med, Inc. provides alternative medicinal procedures, premium nutritional supplements, medicinal products and current medical support services by making them available to patients through their clinics and online through e-commerce purchasing applications. Therma-Med, Inc., through highly specialized Thermal Imaging and breakthrough alternative procedure clinics, is poised to become a healthcare industry leading company, providing the alternative medicine approach to good health, as well as providing patients with an adjunctive diagnostic procedure that effectively pursues and exposes the benefits of early detection and prevention of various medical conditions. Therma-Med, Inc. utilizes thermal imaging systems that incorporate state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body, allowing patients of all walks of life access to a proactive form of maintaining good health and quality of life through early detection and prevention.
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Therma Med, Inc. with members of its management team as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.